Science Explorer Back to mapMap
Discussion
Researcher · Chinese Academy of Medical Sciences & Peking Union Medical College · China

Jian Li

Jian Li publishes mostly in Molecular Biology, Oncology and Hematology, on topics such as Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.

ORCID 0000-0002-4549-0694 OpenAlex
World rank
#4,923,930
of 7,710,434 ranked researchers
Rank in China
#738,237
of 978,568
Works
1,866
Citations
14k
Citations per work
7.7
h-index
50
i10-index 345Top 3.7% in Molecular Biology
Jian Li

What does Jian Li research?

Jian Li's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (10%).

Everything else: 1,121 works · 60.1% of their workHealth Sciences: 550 works · 29.5% of their workMedicine: 550 works · 29.5% of their workOncology: 134 works · 7.2% of their workHematology: 127 works · 6.8% of their workSurgery: 116 works · 6.2% of their workPulmonary and Respiratory Medicine: 88 works · 4.7% of their workGenetics: 86 works · 4.6% of their workLife Sciences: 194 works · 10.4% of their workBiochemistry, Genetics and Molecular Biology: 194 works · 10.4% of their workMolecular Biology: 194 works · 10.4% of their workTHEIR WORKJian Li1,866works
Life Sciences10%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1,12160.1%
    1. Medicine55029.5%
    1. Biochemistry, Genetics and Molecular Biology19410.4%
  1. 1Molecular Biology10% of their works
  2. 2Oncology7% of their works
  3. 3Hematology7% of their works
  4. 4Surgery6% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Jian Li's research?

The keywords of their largest research topics: Rituximab, Diagnosis, Treatment, Pathogenesis, Prognostic Factors, Diagnosis Criteria, International Myeloma Working Group and Chronic Lymphocytic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Rituximab1342 topics
  2. Diagnosis1282 topics
  3. Treatment1282 topics
  4. Pathogenesis1152 topics
  5. Prognostic Factors1122 topics
  6. Diagnosis Criteria851 topic
  7. International Myeloma Working Group851 topic
  8. Chronic Lymphocytic Leukemia671 topic
  9. Classification671 topic
  10. Genomic Aberrations671 topic
  11. Lymphoma671 topic
  12. Chronic Inflammatory Demyelinating Polyradiculoneuropathy651 topic
  13. Guillain-Barré Syndrome651 topic
  14. Cardiac Amyloidosis631 topic
  15. Transthyretin631 topic
  16. Epstein-Barr Virus581 topic
  17. Kaposi's Sarcoma581 topic
  18. Erdheim-Chester Disease501 topic
  19. Langerhans Cell Histiocytosis501 topic
  20. AML451 topic
  21. Acute Myeloid Leukemia451 topic

Where does Jian Li work?

Jian Li's main affiliation in the publication record is Chinese Academy of Medical Sciences & Peking Union Medical College, China.

How many publications and citations does Jian Li have?

OpenAlex counts 1,866 works and 14,412 citations for Jian Li, an h-index of 50, ranking #4,923,930 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Jian Li

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jian Li. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.